Venostent

VenoStent is a clinical-stage medical device company based in Houston, Texas, developing SelfWrap, a bioabsorbable perivascular wrap designed to reduce arteriovenous (AV) access-site failures in chronic kidney disease patients requiring hemodialysis. The company combines biomedical engineering, materials science, and medical 3D printing to improve the maturation and durability of dialysis access, where an estimated 50-60% of access sites fail within the first year. SelfWrap holds FDA Breakthrough Device Designation (2022) and is being evaluated in a 200-subject US clinical trial. VenoStent is backed by Norwest Venture Partners, IAG Capital, and Y Combinator, with additional support from the NSF and NIH. This is a medical device / healthcare company with no public API or developer surface; profiled in the API Evangelist network for portfolio and market context.

Venostent is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, MedTech, Healthcare, and Dialysis.

Venostent’s developer surface includes engineering blog, support, and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub
8.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyMedical DevicesMedTechHealthcareDialysisVascular AccessNephrologyBioabsorbable Implants

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 8.8/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 1.3 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/venostent: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Venostent Domain Security

TLSv1.3 · HSTS

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support
Support

Company 4

The organization behind the API

Website
Website
 About
About
 Blog
Blog
 LinkedIn
LinkedIn

Source (apis.yml)

apis.yml Raw ↑ 
aid: venostent
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/venostent.png
name: Venostent
description: VenoStent is a clinical-stage medical device company based in Houston, Texas, developing SelfWrap, a bioabsorbable
  perivascular wrap designed to reduce arteriovenous (AV) access-site failures in chronic kidney disease patients requiring
  hemodialysis. The company combines biomedical engineering, materials science, and medical 3D printing to improve the maturation
  and durability of dialysis access, where an estimated 50-60% of access sites fail within the first year. SelfWrap holds
  FDA Breakthrough Device Designation (2022) and is being evaluated in a 200-subject US clinical trial. VenoStent is backed
  by Norwest Venture Partners, IAG Capital, and Y Combinator, with additional support from the NSF and NIH. This is a medical
  device / healthcare company with no public API or developer surface; profiled in the API Evangelist network for portfolio
  and market context.
url: https://raw.githubusercontent.com/api-evangelist/venostent/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- norwest-venture-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Medical Devices
- MedTech
- Healthcare
- Dialysis
- Vascular Access
- Nephrology
- Bioabsorbable Implants
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://venostent.com
- type: About
  url: https://venostent.com/company
- type: Blog
  url: https://venostent.com/press
  name: News & Press
- type: Support
  url: mailto:info@venostent.com
  name: Contact
- type: LinkedIn
  url: https://www.linkedin.com/company/venostent
- type: DomainSecurity
  url: security/venostent-domain-security.yml
  name: Domain Security (TLS/HSTS/DNS)
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1